 |
 |

Family History of Alcoholism and Hypothalamic Opioidergic Activity
Gary S. Wand, MD;
Deborah Mangold, MA;
Samer El Deiry, MD, PhD;
Mary E. McCaul, PhD;
Donald Hoover, PhD
Arch Gen Psychiatry. 1998;55:1114-1119.
Background This study was designed to assess whether nonalcoholic offspring from families with a high density of alcohol-dependent individuals have altered endogenous central nervous system opioid activity. Naloxone hydrochloride stimulates plasma cortisol by blocking opioidergic input on the corticotropin-releasing factor neuron, thereby providing a noninvasive method for measuring hypothalamic opioid tone.
Methods Forty-eight nonalcoholic subjects aged 18 to 25 years were enrolled in a protocol to measure endogenous opioid activity by inducing opioid receptor blockade with the receptor antagonist, naloxone. Twenty-six subjects were offspring from families with a high density of alcohol dependence and were designated as family historypositive subjects. Twenty-two subjects were biological offspring of nonalcohol-dependent parents and designated as family historynegative subjects. Subjects received naloxone hydrochloride (0, 125, and 375 µg/kg) in double-blind, randomized order. Serum cortisol levels were monitored.
Results Family historynegative subjects had a graded cortisol response to each dose of naloxone. In contrast, family historypositive subjects achieved a maximal cortisol response to the 125-µg/kg dose of naloxone hydrochloride with no further increase in cortisol levels observed following the 375-µg/kg dose. Family historynegative subjects had a diminished cortisol response to the 125-µg/kg dose compared with the family historypositive subjects. Plasma naloxone concentrations did not differ between family history groups.
Conclusions Individuals from families with a high density of alcohol dependence are more sensitive to naloxone compared with offspring of nonalcohol-dependent parents. This implies that individuals with a family history of alcohol dependence have diminished endogenous hypothalamic opioid activity.
From The Johns Hopkins University School of Medicine (Drs Wand, El Deiry, and McCaul and Ms Mangold) and The Johns Hopkins University School of Public Health (Dr Hoover), Baltimore, Md.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma et al.
Alcohol Alcohol 2002;37:522-533.
ABSTRACT
| FULL TEXT
Role of Protein Kinase C in Control of Ethanol-Modulated beta -Endorphin Release from Hypothalamic Neurons in Primary Cultures
De et al.
J. Pharmacol. Exp. Ther. 2002;301:119-128.
ABSTRACT
| FULL TEXT
PLASMA LEVELS OF BETA-ENDORPHIN, ADRENOCORTICOTROPIC HORMONE AND CORTISOL DURING EARLY AND LATE ALCOHOL WITHDRAWAL
Esel et al.
Alcohol Alcohol 2001;36:572-576.
ABSTRACT
| FULL TEXT
TRAIT MARKERS FOR ALCOHOLISM: CLINICAL UTILITY
Farren and Tipton
Alcohol Alcohol 1999;34:649-665.
ABSTRACT
| FULL TEXT
Naloxone Challenge in Smokers: Preliminary Evidence of an Opioid Component in Nicotine Dependence
Krishnan-Sarin et al.
Arch Gen Psychiatry 1999;56:663-668.
ABSTRACT
| FULL TEXT
|